This reduces phosphorylation levels of Sp1 at Ser/Thr, further increasing TGFβ1 and PAI-1 transcription, leading to decreased cardiac systolic function and accelerating diabetic cardiomyopathy progression. Here, SP1 is linked to diabetic cardiomyopathy.